CoEHAR interview: Ang Sun
Interview with prof. Prof. Ang Sun, of the Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University (USA),…
CoEHAR interview: Robert Sussman
CoEHAR interview with prof. Robert Sussman of Universidad Nacional Autónoma de México and Visiting Professor of the University of Catania. How many smokers are there in Mexico? e-cigarettes and heat…
CoEHAR interview: Attaullah Ahmadi
CoEHAR interview with prof. Attaullah Ahmadi, visiting researcher della French School of Public Health e Global Health Focus presso il Dipartimento di Medicina Clinica e Sperimentale dell'Università di Catania. https://www.youtube.com/watch?v=MeaAmfnw4WU
Italian Parliament – Polosa: “Integrating the principle of harm reduction to bring smokers from 25 to 5%”
This was stated by prof. Riccardo Polosa, founder of CoEHAR, Research Center for the reduction of harm from smoking, and full professor of Internal Medicine at the University of Catania, yesterday in a hearing in the Social Affairs Commission of the Chamber, in the context of the examination of the Communication from the Commission to the European Parliament and the Council on the ‘European plan to fight against cancer’.
CoEHAR hosts a lectio magistralis with prof. Ang Sun of Temple University
Prof. Ang Sun of Temple University (USA) will hold a seminar on THR research on 11th July at 11am at the University of Catania.
Just published the first randomized controlled trial of varenicline for vaping cessation
The use of the drug combined with an innovative vaping cessation counseling program was safe and effective for quitting e-cigarettes. The combined approach also decreased the chances of relapsing back to vaping and smoking.
Diasmoke Working Group in Warsaw: how to address the smoking issue among diabetes patients?
During the 2023 edition of the GFN, a pool of international diabetologists, coordinated by CoEHAR, addressed the issue of cigarette smoking among diabetes patients, setting new international treatment guidelines to be published soon.
VERITAS COHORT: the project takes off as 27 countries are involved all over the World
In May, CoEHAR has launched one of its most ambitious project, the Veritas Cohort study. Now, more than 400 people from 27 different countries are involved and numbers keep increasing.
At GFN 2023, SAB Diasmoke second meeting
GFN 2023 will start tomorrow at Varsavia. The 10th edition of the Global Forum on Nicotine, from 21 to 24 June, will host more events dedicated to harm reduction research. During this edition will be also the second meeting of SAB Diasmoke. Diabetologists and experts on THR signed the guidelines on the treatment of smokers with diabetes.
Replica 2.0 on site training in Serbia
Aim of the trip was to conduct and perform further technical training of the partners on biological endpoints and dissemination of Tobacco Harm Reduction mission and research.
